#Biopharmaceuticals

Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies

Dia Beta Labs secured €1.4 million in funding from undisclosed investors. This investment will advance its development of next-generation therapies for obesity and Type 2 diabetes. The company's technology focuses on protecting and repairing insulin-producing beta-cells.

British EnsiliTech Secures €5.2M Seed for Cold-Chain Biopharma

EnsiliTech secured €5.2 million in Seed funding, led by Eos Advisory. This capital will advance its patented Ensilication technology, which stabilizes biopharmaceuticals at higher temperatures. The innovation aims to eliminate cold-chain reliance, revolutionizing global biopharma transport.

MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry